Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Repros tanks on another FDA hurdle for its 'low-T' treatment
Repros tanks on another FDA hurdle for its 'low-T' treatment
Repros tanks on another FDA hurdle for its 'low-T' treatment
Submitted by
admin
on October 30, 2015 - 9:51am
Source:
Fierce Biotech
News Tags:
Repros Therapeutics
testosterone
FDA
Androxal
Headline:
Repros tanks on another FDA hurdle for its 'low-T' treatment
Do Not Allow Advertisers to Use My Personal information
